Neal Walker

Neal Walker

Chief Executive OfficeratAclaris Therapeutics· In proxies 2023–2025

Pay in FY2025+134% from the year before · Aclaris Therapeutics stock +21.4% the same year

Neal Walker was paid $3.4M in FY2025 (Dec), up 134%. Aclaris Therapeutics stock rose 21.4% that year.

Pay$100 in the stock at the end of FY23 → $287
Pay is from the Summary Compensation Table of each Aclaris Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aclaris TherapeuticsPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role -74%
  2. Aldeyra Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?